Nanda Bondade
Examiner (ID: 1930)
Most Active Art Unit | 2912 |
Art Unit(s) | 2902, 2900, 2912 |
Total Applications | 5029 |
Issued Applications | 4983 |
Pending Applications | 0 |
Abandoned Applications | 46 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 18893653
[patent_doc_number] => 20240009138
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-11
[patent_title] => EDIBLE GRAPHIC DRUG DELIVERY SYSTEM AND METHOD OF MANUFACTURE
[patent_app_type] => utility
[patent_app_number] => 18/355325
[patent_app_country] => US
[patent_app_date] => 2023-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2733
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -38
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18355325
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/355325 | EDIBLE GRAPHIC DRUG DELIVERY SYSTEM AND METHOD OF MANUFACTURE | Jul 18, 2023 | Pending |
Array
(
[id] => 18565813
[patent_doc_number] => 20230256140
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => ANTIMICROBIAL COATINGS FOR MEDICAL DEVICES
[patent_app_type] => utility
[patent_app_number] => 18/308409
[patent_app_country] => US
[patent_app_date] => 2023-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6140
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18308409
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/308409 | ANTIMICROBIAL COATINGS FOR MEDICAL DEVICES | Apr 26, 2023 | Pending |
Array
(
[id] => 18986298
[patent_doc_number] => 20240058267
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-22
[patent_title] => SLURRY AND SOLUTION COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 18/140124
[patent_app_country] => US
[patent_app_date] => 2023-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5102
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18140124
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/140124 | SLURRY AND SOLUTION COMPOSITIONS | Apr 26, 2023 | Pending |
Array
(
[id] => 18565812
[patent_doc_number] => 20230256139
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => IMPLANT SURFACES FOR PAIN CONTROL
[patent_app_type] => utility
[patent_app_number] => 18/138588
[patent_app_country] => US
[patent_app_date] => 2023-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16983
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18138588
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/138588 | IMPLANT SURFACES FOR PAIN CONTROL | Apr 23, 2023 | Pending |
Array
(
[id] => 18595893
[patent_doc_number] => 20230270683
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-31
[patent_title] => TWO SPEED MONOLITHIC SYSTEM FOR CONTROLLED RELEASE OF DRUGS
[patent_app_type] => utility
[patent_app_number] => 18/134687
[patent_app_country] => US
[patent_app_date] => 2023-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9065
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18134687
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/134687 | TWO SPEED MONOLITHIC SYSTEM FOR CONTROLLED RELEASE OF DRUGS | Apr 13, 2023 | Pending |
Array
(
[id] => 18708029
[patent_doc_number] => 20230330614
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-19
[patent_title] => PYRACLOSTROBIN MICROCAPSULE BASED ON SODIUM ALGINATE AND PREPARATION METHOD
[patent_app_type] => utility
[patent_app_number] => 18/131871
[patent_app_country] => US
[patent_app_date] => 2023-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8996
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18131871
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/131871 | Pyraclostrobin microcapsule based on sodium alginate and preparation method | Apr 6, 2023 | Issued |
Array
(
[id] => 18483455
[patent_doc_number] => 20230210750
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => Organic Compounds
[patent_app_type] => utility
[patent_app_number] => 18/174233
[patent_app_country] => US
[patent_app_date] => 2023-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8852
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18174233
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/174233 | Organic Compounds | Feb 23, 2023 | |
Array
(
[id] => 18389730
[patent_doc_number] => 20230157948
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => ORALLY DISINTEGRATING TABLET COMPRISING AMORPHOUS SOLID DISPERSION OF NILOTINIB
[patent_app_type] => utility
[patent_app_number] => 18/100104
[patent_app_country] => US
[patent_app_date] => 2023-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47698
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18100104
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/100104 | ORALLY DISINTEGRATING TABLET COMPRISING AMORPHOUS SOLID DISPERSION OF NILOTINIB | Jan 22, 2023 | Pending |
Array
(
[id] => 18389790
[patent_doc_number] => 20230158008
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => METHODS AND COMPOSITIONS FOR SELF-REGULATED RELEASE OF ACTIVE PHARMACEUTICAL INGREDIENTS
[patent_app_type] => utility
[patent_app_number] => 18/080379
[patent_app_country] => US
[patent_app_date] => 2022-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16434
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18080379
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/080379 | METHODS AND COMPOSITIONS FOR SELF-REGULATED RELEASE OF ACTIVE PHARMACEUTICAL INGREDIENTS | Dec 12, 2022 | Pending |
Array
(
[id] => 18404453
[patent_doc_number] => 20230165803
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-01
[patent_title] => BIOPOLYMER-ENCAPSULATED GLYCOSYLTRANSFERASE INHIBITOR COMPOSITIONS AND METHODS FOR TREATING DIABETES AND CARDIAC INDICATIONS
[patent_app_type] => utility
[patent_app_number] => 17/993555
[patent_app_country] => US
[patent_app_date] => 2022-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15316
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17993555
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/993555 | BIOPOLYMER-ENCAPSULATED GLYCOSYLTRANSFERASE INHIBITOR COMPOSITIONS AND METHODS FOR TREATING DIABETES AND CARDIAC INDICATIONS | Nov 22, 2022 | Pending |
Array
(
[id] => 18626606
[patent_doc_number] => 20230285400
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => PHARMACEUTICAL COMPOSITIONS COMPRISING (S)-2-(2,6-DIOXOPIPERIDIN-3-YL)-4-((2-FLUORO-4-((3-MORPHOLINOAZETIDIN-1-YL)METHYL)BENZYL)AMINO)ISOINDOLINE-1,3-DIONE AND METHODS OF USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/982024
[patent_app_country] => US
[patent_app_date] => 2022-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27599
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17982024
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/982024 | PHARMACEUTICAL COMPOSITIONS COMPRISING (S)-2-(2,6-DIOXOPIPERIDIN-3-YL)-4-((2-FLUORO-4-((3-MORPHOLINOAZETIDIN-1-YL)METHYL)BENZYL)AMINO)ISOINDOLINE-1,3-DIONE AND METHODS OF USING THE SAME | Nov 6, 2022 | Pending |
Array
(
[id] => 18296201
[patent_doc_number] => 20230105887
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => NOVEL PHARMACEUTICAL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 18/047180
[patent_app_country] => US
[patent_app_date] => 2022-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11271
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18047180
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/047180 | NOVEL PHARMACEUTICAL COMPOSITION | Oct 16, 2022 | Pending |
Array
(
[id] => 18164922
[patent_doc_number] => 20230031519
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-02
[patent_title] => COMPOSITION COMPRISING MELATONIN OR ITS DERIVATIVES WITH COENZYME Q10 AND USE THEREOF AGAINST AGEING OF THE SKIN
[patent_app_type] => utility
[patent_app_number] => 17/936733
[patent_app_country] => US
[patent_app_date] => 2022-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6259
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17936733
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/936733 | COMPOSITION COMPRISING MELATONIN OR ITS DERIVATIVES WITH COENZYME Q10 AND USE THEREOF AGAINST AGEING OF THE SKIN | Sep 28, 2022 | Abandoned |
Array
(
[id] => 18252667
[patent_doc_number] => 20230079706
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => Solid Cleansing Compositions and Methods for the Same
[patent_app_type] => utility
[patent_app_number] => 17/943103
[patent_app_country] => US
[patent_app_date] => 2022-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12244
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17943103
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/943103 | Solid Cleansing Compositions and Methods for the Same | Sep 11, 2022 | Pending |
Array
(
[id] => 18281837
[patent_doc_number] => 20230097309
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => SOLID DISPERSIONS OF A ERB2 (HER2) INHIBITOR
[patent_app_type] => utility
[patent_app_number] => 17/895951
[patent_app_country] => US
[patent_app_date] => 2022-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9486
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17895951
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/895951 | SOLID DISPERSIONS OF A ERB2 (HER2) INHIBITOR | Aug 24, 2022 | Pending |
Array
(
[id] => 18056241
[patent_doc_number] => 20220387327
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => METHOD OF MANUFACTURING PHARMACEUTICAL COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/820781
[patent_app_country] => US
[patent_app_date] => 2022-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17345
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17820781
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/820781 | METHOD OF MANUFACTURING PHARMACEUTICAL COMPOSITIONS | Aug 17, 2022 | Abandoned |
Array
(
[id] => 18034573
[patent_doc_number] => 20220378788
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => ORALLY DISINTEGRATING TABLET COMPRISING AMORPHOUS SOLID DISPERSION OF NILOTINIB AND IN VITRO CHARACTERIZATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/881390
[patent_app_country] => US
[patent_app_date] => 2022-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52736
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 161
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17881390
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/881390 | ORALLY DISINTEGRATING TABLET COMPRISING AMORPHOUS SOLID DISPERSION OF NILOTINIB AND IN VITRO CHARACTERIZATION THEREOF | Aug 3, 2022 | Pending |
Array
(
[id] => 18018949
[patent_doc_number] => 20220370448
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => PHARMACEUTICAL COMPOSITION COMPRISING THIRD GENERATION SMALL MOLECULE EGFR INHIBITOR AND PREPARATION METHOD THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/875811
[patent_app_country] => US
[patent_app_date] => 2022-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6446
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17875811
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/875811 | PHARMACEUTICAL COMPOSITION COMPRISING THIRD GENERATION SMALL MOLECULE EGFR INHIBITOR AND PREPARATION METHOD THEREOF | Jul 27, 2022 | Pending |
Array
(
[id] => 18221187
[patent_doc_number] => 20230060181
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => ENVIRONMENTALLY BIODEGRADABLE MICROCAPSULES
[patent_app_type] => utility
[patent_app_number] => 17/861204
[patent_app_country] => US
[patent_app_date] => 2022-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19576
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17861204
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/861204 | ENVIRONMENTALLY BIODEGRADABLE MICROCAPSULES | Jul 8, 2022 | Pending |
Array
(
[id] => 17944289
[patent_doc_number] => 20220331306
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-20
[patent_title] => Nicotine Pouch
[patent_app_type] => utility
[patent_app_number] => 17/853545
[patent_app_country] => US
[patent_app_date] => 2022-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8143
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17853545
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/853545 | Nicotine Pouch | Jun 28, 2022 | Pending |